🔬 Research

Scientific research, clinical trials and evidence base

14 articles

Берберин vs Мунджаро — капсули берберину та ручка KwikPen на світлій поверхні, порівняння добавки та GLP-1 препарату
Weight Loss
11 min
11 min read

Berberine vs Ozempic: Why a Plant Supplement Cannot Replace a GLP-1 Injection

Berberine is called nature's Ozempic, but meta-analyses show only 2 kg weight loss versus 15% on semaglutide. We break down the mechanisms, dosing, and honest data.

D
DOZA Team
berberineozempic
Натуральні альтернативи Оземпіку та Мунджаро — порівняння БАДів берберину та GLP-1 агоністів DOZA
Weight Loss
14 min
14 min read

Berberine, GLP-1 Boosters, and Weight Loss Supplements: An Honest Analysis of What Actually Works

What research really shows about berberine, natural GLP-1 boosters, and weight loss supplements. Comparing with the proven efficacy of Ozempic and Mounjaro.

D
DOZA Team
berberinenatural ozempic
Інгібітори міостатину Мунджаро (Mounjaro) — ручка KwikPen та анатомія м'язового волокна, майбутнє схуднення без втрати м'язів
🔬Research
9 min
9 min read

Weight Loss Without Muscle Loss: How Myostatin Inhibitors Will Transform Mounjaro and Ozempic Treatment

The EMBRAZE 2026 study showed: apitegromab preserves 54.9% more muscle mass during weight loss on tirzepatide. What this means for Mounjaro and Ozempic users.

D
DOZA Team
myostatin inhibitorsapitegromab
Кагрісема (CagriSema) та Оземпік (Ozempic) — порівняння продуктів для схуднення на білому фоні, преміум фармацевтична фотографія
🧪GLP-1 Agonists
11 min
11 min read

CagriSema: Will the New Duo Outperform Mounjaro and Ozempic

CagriSema combines semaglutide with amylin and shows 22.7% weight loss. But will it beat tirzepatide? We analyze the REDEFINE and REIMAGINE results.

D
DOZA Team
cagrisemaamylin
Орфорглипрон (Foundayo) таблетка vs Мунджаро (Mounjaro) та Оземпік (Ozempic) — порівняння GLP-1 для схуднення
🧪GLP-1 Agonists
10 min
10 min read

Orforglipron (Foundayo): The First Weight Loss Pill You Can Take Without Restrictions — What the Studies Show

Orforglipron was approved by the FDA in April 2026. We compare it with Mounjaro and Ozempic: effectiveness 12.4% vs 22.5%, side effects, and when it will be available in Ukraine.

D
DOZA Team
orforglipronfoundayo
Woman studying SURMOUNT-1 tirzepatide Mounjaro clinical trial results at DOZA
🔬Research
14 min
14 min read

SURMOUNT-1: How 2539 People Lost Up to 22.5% Weight in 72 Weeks — Complete Analysis of Revolutionary Study

Detailed analysis of the largest tirzepatide study: methodology, dosing, primary and secondary outcomes, safety profile and comparison with other SURMOUNT programs.

D
DOZA Team
surmount-1tirzepatide
💊

Ready to lose weight with Mounjaro?

Free specialist consultation — we'll select the right dose and program for you

Consultation →
SELECT trial Ozempic - semaglutide cardioprotective effect study on 17,604 patients
🔬Research
12 min
12 min read

SELECT: The Study That Changed Understanding of Ozempic's Cardiovascular Impact

17,604 patients, 4 years of follow-up, 20% reduction in heart attack and stroke risk. Breaking down the SELECT study that became the basis for FDA's new cardiovascular indication.

D
DOZA Team
select trialozempic
Epitalon telomerase peptide Khavinson — 55-year-old woman morning meditation anti-aging Kyiv
🧬Peptides
16 min
16 min read

Epitalon: Khavinson's tetrapeptide that activates telomerase — 2026 protocol and honest evidence review

Epitalon is a tetrapeptide Ala-Glu-Asp-Gly from Khavinson's school that activates telomerase. Anisimov 2006: +25-50% mice lifespan extension. 10-day protocol, limitations, synergy.

D
DOZA Team
epitalontelomerase
Woman 40-48 in cream cashmere near window Kyiv apartment — NMN преcourseор NAD+, anti-aging
🧬Peptides
12 min
12 min read

NMN: How NAD+ Precursor Works and Why It's Not a Fountain of Youth

NMN increases NAD+ by 29% in 8 weeks. Harvard research, 500-1000 mg protocol, comparison with NR and injections. What actually works for anti-aging.

D
DOZA Team
NMNNAD+
Amilin Cagrilintide — woman with peptide vial for weight loss at Ukraine pharmacy DOZA
🧬Peptides
12 min
12 min read

Amylin: The Satiety Hormone Doctors Don't Discuss

Cagrilintide (Amylin) is a long-acting analog of the amylin hormone. It works through a different pathway than Ozempic or Mounjaro. CagriSema showed -22.7% weight loss over 68 weeks.

D
DOZA Team
cagrilintideamylin
Retatrutide side effects - SYNEDICA and ALLUVI products on DOZA specialist's desk
🧪GLP-1 Agonists
10 min
10 min read

Retatrutide Side Effects: Complete Analysis vs Mounjaro and Ozempic

What to expect on Retatrutide, side effect profile, and how the triple mechanism changes the experience compared to Mounjaro and Ozempic.

D
DOZA Team
retatrutideside effects
ALLUVI Retatrutide injection pen - triple GLP-1/GIP/glucagon agonist for DOZA weight loss program
🧪GLP-1 Agonists
13 min
13 min read

Retatrutide: Why the Triple Agonist is Called the "Heavy Artillery" of Weight Loss

The first drug to activate three receptors simultaneously: GLP-1, GIP, and glucagon. Minus 24% weight in 48 weeks — but should you start with this one?

D
DOZA Team
retatrutidetriple agonist